$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2018 Q1 Form 10-Q Financial Statement

#000139681418000014 Filed on May 03, 2018

Income Statement

Concept	2018 Q1	2017 Q1
Revenue	$74.61M	$69.28M
YoY Change	7.68%	5.82%
Cost Of Revenue	$22.89M	$24.58M
YoY Change	-6.9%	21.22%
Gross Profit	$51.72M	$44.70M
YoY Change	15.7%	-1.09%
Gross Profit Margin	69.33%	64.52%
Selling, General & Admin	$44.19M	$42.12M
YoY Change	4.92%	10.97%
% of Gross Profit	85.44%	94.22%
Research & Development	$14.38M	$16.63M
YoY Change	-13.55%	75.2%
% of Gross Profit	27.8%	37.21%
Depreciation & Amortization	$2.762M	$3.104M
YoY Change	-11.02%	-1.93%
% of Gross Profit	5.34%	6.94%
Operating Expenses	$81.54M	$83.33M
YoY Change	-2.15%	23.04%
Operating Profit	-$6.937M	-$14.05M
YoY Change	-50.63%	523.34%
Interest Expense	$5.157M	$2.589M
YoY Change	99.19%	38.6%
% of Operating Profit
Other Income/Expense, Net	-$3.708M	-$5.786M
YoY Change	-35.91%	269.01%
Pretax Income	-$10.65M	-$19.84M
YoY Change	-46.33%	419.0%
Income Tax	$35.00K	$30.00K
% Of Pretax Income
Net Earnings	-$10.68M	-$19.87M
YoY Change	-46.24%	415.46%
Net Earnings / Revenue	-14.32%	-28.67%
Basic Earnings Per Share	-$0.26	-$0.52
Diluted Earnings Per Share	-$262.9K	-$523.7K
COMMON SHARES
Basic Shares Outstanding	40.71M shares	38.00M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2018 Q1	2017 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$339.8M	$383.7M
YoY Change	-11.44%	155.8%
Cash & Equivalents	$41.56M	$109.0M
Short-Term Investments	$298.2M	$274.7M
Other Short-Term Assets	$7.700M	$6.300M
YoY Change	22.22%	-30.0%
Inventory	$40.04M	$30.31M
Prepaid Expenses
Receivables	$31.20M	$27.70M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$418.7M	$448.0M
YoY Change	-6.53%	80.18%
LONG-TERM ASSETS
Property, Plant & Equipment	$109.2M	$102.6M
YoY Change	6.49%	7.02%
Goodwill	$57.49M	$48.83M
YoY Change	17.74%	48.94%
Intangibles
YoY Change
Long-Term Investments	$35.80M
YoY Change
Other Assets	$759.0K	$598.0K
YoY Change	26.92%	24.32%
Total Long-Term Assets	$203.3M	$152.0M
YoY Change	33.75%	6.6%
TOTAL ASSETS
Total Short-Term Assets	$418.7M	$448.0M
Total Long-Term Assets	$203.3M	$152.0M
Total Assets	$622.0M	$600.0M
YoY Change	3.68%	53.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.91M	$9.373M
YoY Change	59.11%	-10.6%
Accrued Expenses	$33.02M	$34.90M
YoY Change	-5.4%	20.07%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$0.00
YoY Change		-100.0%
Long-Term Debt Due		$800.0K
YoY Change
Total Short-Term Liabilities	$48.37M	$45.65M
YoY Change	5.96%	-68.76%
LONG-TERM LIABILITIES
Long-Term Debt	$279.7M	$266.0M
YoY Change	5.15%
Other Long-Term Liabilities	$15.46M	$10.33M
YoY Change	49.66%	-6.24%
Total Long-Term Liabilities	$15.46M	$10.33M
YoY Change	49.66%	-6.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$48.37M	$45.65M
Total Long-Term Liabilities	$15.46M	$10.33M
Total Liabilities	$343.5M	$329.3M
YoY Change	4.31%	99.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$398.5M	-$366.4M
YoY Change	8.75%	17.38%
Common Stock	$41.00K	$40.00K
YoY Change	2.5%	8.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares	0.000 shares	0.000 shares
Shareholders Equity	$278.5M	$270.6M
YoY Change
Total Liabilities & Shareholders Equity	$622.0M	$600.0M
YoY Change	3.68%	53.36%

Cashflow Statement

Concept	2018 Q1	2017 Q1
OPERATING ACTIVITIES
Net Income	-$10.68M	-$19.87M
YoY Change	-46.24%	415.46%
Depreciation, Depletion And Amortization	$2.762M	$3.104M
YoY Change	-11.02%	-1.93%
Cash From Operating Activities	-$2.690M	$10.00K
YoY Change	-27000.0%	-100.32%
INVESTING ACTIVITIES
Capital Expenditures	$5.184M	$3.616M
YoY Change	43.36%	-48.73%
Acquisitions
YoY Change
Other Investing Activities	-$5.110M	-$140.2M
YoY Change	-96.36%	846.15%
Cash From Investing Activities	-$10.29M	-$143.8M
YoY Change	-92.85%	557.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$419.0K	$216.9M
YoY Change	-99.81%	7031.08%
NET CHANGE
Cash From Operating Activities	-2.690M	10.00K
Cash From Investing Activities	-10.29M	-143.8M
Cash From Financing Activities	$419.0K	$216.9M
Net Change In Cash	$419.0K	$216.9M
YoY Change	-99.81%	7031.08%
FREE CASH FLOW
Cash From Operating Activities	-$2.690M	$10.00K
Capital Expenditures	$5.184M	$3.616M
Free Cash Flow	-$7.874M	-$3.606M
YoY Change	118.36%	-64.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2018Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2018Q1	dei	Amendment Flag AmendmentFlag	false
CY2018Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2018Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2018
CY2018Q1	dei	Document Period End Date DocumentPeriodEndDate	2018-03-31
CY2018Q1	dei	Document Type DocumentType	10-Q
CY2018Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2018Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40732255	shares
CY2018Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2018Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2018Q1	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2017Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	168000	USD
CY2018Q1	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	391000	USD
CY2017Q1	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	206000	USD
CY2018Q1	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	0	USD
CY2017Q1	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	207000	USD
CY2018Q1	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	201000	USD
CY2017Q1	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	5917000	USD
CY2018Q1	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	6356000	USD
CY2017Q1	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	53000	USD
CY2018Q1	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	38000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2017Q1	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	284000	USD
CY2018Q1	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2018Q1	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
CY2018Q1	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	0	shares
CY2018Q1	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	100000	USD
CY2018Q1	pcrx	Deferred Tax Liability Convertible Senior Notes Conversion DeferredTaxLiabilityConvertibleSeniorNotesConversion	26500000	USD
CY2018Q1	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	337000	USD
CY2018Q1	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	54000	USD
CY2017Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1274000	USD
CY2018Q1	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1031000	USD
CY2017Q1	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	120466000	USD
CY2018Q1	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	59800000	USD
CY2018Q1	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	62400000	USD
CY2018Q1	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	2293000	USD
CY2017Q1	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-19836000	USD
CY2018Q1	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-10645000	USD
CY2017Q1	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2018Q1	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2017Q1	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	-1179000	USD
CY2018Q1	pcrx	Increase Decreasein Accrued Fixed Assets IncreaseDecreaseinAccruedFixedAssets	233000	USD
CY2017Q4	pcrx	Investments Contingent Purchase Obligation InvestmentsContingentPurchaseObligation	900000	USD
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2018Q1	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2017Q1	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	2092000	USD
CY2018Q1	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	2293000	USD
CY2018Q1	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2018Q1	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	-56000	USD
CY2018Q1	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	33500000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14658000	USD
CY2018Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	14913000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31658000	USD
CY2018Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31203000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41159000	USD
CY2018Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	33017000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49210000	USD
CY2018Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	51972000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-454000	USD
CY2018Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-901000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	669032000	USD
CY2018Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	677836000	USD
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	-125811000	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	0	USD
CY2018Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8385000	USD
CY2017Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7400000	USD
CY2018Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8385000	USD
CY2017Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2018Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	USD
CY2017Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1411000	USD
CY2018Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3113000	USD
CY2017Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7127000	shares
CY2018Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5558000	shares
CY2017Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	236000	USD
CY2018Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	275000	USD
CY2018Q1	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	13000	USD
CY2017Q4	us-gaap	Assets Assets	628371000	USD
CY2018Q1	us-gaap	Assets Assets	622037000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	391110000	USD
CY2018Q1	us-gaap	Assets Current AssetsCurrent	418734000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	10000000	USD
CY2018Q1	us-gaap	Business Exit Costs1 BusinessExitCosts1	16000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2016Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	108970000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2018Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41563000	USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2018Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40668877	shares
CY2018Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40720038	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40668877	shares
CY2018Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40720038	shares
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2018Q1	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-19918000	USD
CY2018Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-11127000	USD
CY2017Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	1000000	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	324000	USD
CY2018Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	327000	USD
CY2017Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	276173000	USD
CY2018Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	279685000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	24581000	USD
CY2018Q1	us-gaap	Cost Of Revenue CostOfRevenue	22885000	USD
CY2018Q1	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	36000	USD
CY2017Q4	us-gaap	Cumulative Effect Of New Accounting Principle In Period Of Adoption CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	1361000	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10000	shares
CY2018Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
CY2018Q1	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2017Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0748
CY2018Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.0781
CY2017Q1	us-gaap	Depreciation Depreciation	3100000	USD
CY2018Q1	us-gaap	Depreciation Depreciation	2800000	USD
CY2017Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3104000	USD
CY2018Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2762000	USD
CY2017Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1510000	USD
CY2018Q1	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1306000	USD
CY2017Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2018Q1	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-90000	USD
CY2018Q1	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	100000	USD
CY2018Q1	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	350000	USD
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2018Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
CY2018Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.26
CY2017Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-137000	USD
CY2018Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3721000	USD
CY2018Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q4	us-gaap	Goodwill Goodwill	55197000	USD
CY2018Q1	us-gaap	Goodwill Goodwill	57490000	USD
CY2012Q2	us-gaap	Goodwill Goodwill	8000000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-19320000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-9813000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19836000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10645000	USD
CY2017Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-516000	USD
CY2018Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-832000	USD
CY2017Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	30000	USD
CY2018Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	35000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1244000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	106000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2235000	USD
CY2018Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-798000	USD
CY2017Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2300000	USD
CY2018Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-7623000	USD
CY2017Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-967000	USD
CY2018Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1368000	USD
CY2017Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1266000	USD
CY2018Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-109000	USD
CY2017Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3051000	USD
CY2018Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1210000	USD
CY2017Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
CY2018Q1	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	400000	USD
CY2017Q1	us-gaap	Interest Expense InterestExpense	2589000	USD
CY2018Q1	us-gaap	Interest Expense InterestExpense	5157000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	2380000	USD
CY2018Q1	us-gaap	Interest Paid InterestPaid	4102000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16540000	USD
CY2018Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	14895000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	41411000	USD
CY2018Q1	us-gaap	Inventory Net InventoryNet	40043000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16500000	USD
CY2018Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16721000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8371000	USD
CY2018Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8427000	USD
CY2017Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	514000	USD
CY2018Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1374000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	348888000	USD
CY2018Q1	us-gaap	Liabilities Liabilities	343516000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	628371000	USD
CY2018Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	622037000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56217000	USD
CY2018Q1	us-gaap	Liabilities Current LiabilitiesCurrent	48368000	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	60047000	USD
CY2018Q1	us-gaap	Long Term Investments LongTermInvestments	21683000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	73026000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-12563000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	216856000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	6000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	419000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-143836000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-10293000	USD
CY2018Q1	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-2689000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-19866000	USD
CY2018Q1	us-gaap	Net Income Loss NetIncomeLoss	-10680000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5786000	USD
CY2018Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3708000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	83333000	USD
CY2018Q1	us-gaap	Operating Expenses OperatingExpenses	81544000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-14050000	USD
CY2018Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-6937000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	51836000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5366000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5245000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7604000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8122000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	19577000	USD
CY2018Q1	us-gaap	Operating Leases Future Minimum Payments Remainder Of Fiscal Year OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear	5922000	USD
CY2018Q1	us-gaap	Other Adjustments To Income Discontinued Operations OtherAdjustmentsToIncomeDiscontinuedOperations	40000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	825000	USD
CY2018Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	759000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-52000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-447000	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-52000	USD
CY2018Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-447000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16498000	USD
CY2018Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15463000	USD
CY2017Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	10000	USD
CY2018Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	75000	USD
CY2017Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
CY2018Q1	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15000000	USD
CY2017Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3616000	USD
CY2018Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5184000	USD
CY2017Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	180342000	USD
CY2018Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	130580000	USD
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2018Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2018Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2018Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2018Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6694000	USD
CY2018Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7700000	USD
CY2017Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
CY2018Q1	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	42214000	USD
CY2018Q1	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	127764000	USD
CY2017Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	852000	USD
CY2018Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	419000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156256000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	161197000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107046000	USD
CY2018Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	109225000	USD
CY2017Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	117712000	USD
CY2018Q1	us-gaap	Repayments Of Debt RepaymentsOfDebt	0	USD
CY2017Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16632000	USD
CY2018Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14378000	USD
CY2017Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1223000	USD
CY2018Q1	us-gaap	Restricted Stock Expense RestrictedStockExpense	1790000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-389136000	USD
CY2018Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-398455000	USD
CY2017Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	68425000	USD
CY2018Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74287000	USD
CY2017Q1	us-gaap	Revenues Revenues	69283000	USD
CY2018Q1	us-gaap	Revenues Revenues	74607000	USD
CY2017Q1	us-gaap	Royalty Revenue RoyaltyRevenue	652000	USD
CY2018Q1	us-gaap	Royalty Revenue RoyaltyRevenue	320000	USD
CY2017Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	68425000	USD
CY2018Q1	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	74287000	USD
CY2017Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42120000	USD
CY2018Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	44191000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7400000	USD
CY2018Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8385000	USD
CY2018Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.19
CY2018Q1	us-gaap	Share Price SharePrice	31.15
CY2018Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.85
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	257221000	USD
CY2018Q1	us-gaap	Short Term Investments ShortTermInvestments	298225000	USD
CY2018Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	0	shares
CY2018Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2018Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	419000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	278521000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14000000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2018Q1	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	76000	USD
CY2018Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	111000	USD
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2018Q1	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37998000	shares
CY2018Q1	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	40707000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37998000	shares

Files In Submission

Name	View Source	Status
0001396814-18-000014-index-headers.html	Edgar Link	pending
0001396814-18-000014-index.html	Edgar Link	pending
0001396814-18-000014.txt	Edgar Link	pending
0001396814-18-000014-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
paciralogoa11.jpg	Edgar Link	pending
pcrx-20180331.xml	Edgar Link	completed
pcrx-20180331.xsd	Edgar Link	pending
pcrx-20180331_cal.xml	Edgar Link	unprocessable
pcrx-20180331_def.xml	Edgar Link	unprocessable
pcrx-20180331_lab.xml	Edgar Link	unprocessable
pcrx-20180331_pre.xml	Edgar Link	unprocessable
pcrx-3312018x10xq.htm	Edgar Link	pending
pcrx-3312018xex101.htm	Edgar Link	pending
pcrx-3312018xex311.htm	Edgar Link	pending
pcrx-3312018xex312.htm	Edgar Link	pending
pcrx-3312018xex321.htm	Edgar Link	pending
pcrx-3312018xex322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2018 Q1 Form 10-Q Financial Statement

#000139681418000014 Filed on May 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2018 Q1 Form 10-Q Financial Statement

#000139681418000014 Filed on May 03, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx